Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, mostly causing respiratory symptoms, is also known to affect the gastrointestinal tract. Several case reports hypothesize that SARS-CoV-2 could be an etiological factor in acute pancreatitis (AP).
Aim: To assess all the available evidence in the literature relating to coronavirus disease 2019 (COVID-19) and AP.
Methods: We performed a systematic review of the available literature on the topic. The systematic search was conducted on 15 May 2020 on MEDLINE, EMBASE, CENTRAL, Web of Science and Scopus with a search key using the terms "amylase," "lipase," "pancr*," "COVID-19" and synonyms. Due to the low quality and poor comparability of the studies, a meta-analysis was not performed.
Results: Six case reports and two retrospective cohorts were included, containing data on eleven COVID-19 patients with AP. Five patients had AP according to the Atlanta classification. Other publications did not provide sufficient information on the diagnostic criteria. Most cases were considered SARS-CoV-2-induced, while several established etiological factors were not investigated. We were able to identify other possible causes in most of them.
Conclusion: We strongly highlight the need for adherence to the guidelines during a diagnostic and etiological workup, which could alter therapy.
Keywords: Amylase; COVID-19; Lipase; Pancreas; Pancreatic involvement; Pancreatitis.
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.